ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,652 | -13.0% | 10,252 | 0.0% | 0.08% | -7.1% |
| Q2 2023 | $245,535 | -12.9% | 10,252 | -24.6% | 0.08% | -16.8% |
| Q3 2018 | $282,000 | +24.2% | 13,593 | -8.6% | 0.10% | +29.5% |
| Q2 2018 | $227,000 | -7.7% | 14,872 | +68.9% | 0.08% | -10.3% |
| Q2 2017 | $246,000 | -21.2% | 8,807 | -3.0% | 0.09% | -18.7% |
| Q1 2017 | $312,000 | +19.1% | 9,083 | 0.0% | 0.11% | +12.6% |
| Q4 2016 | $262,000 | -9.3% | 9,083 | 0.0% | 0.10% | -13.6% |
| Q3 2016 | $289,000 | +2.1% | 9,083 | +4.0% | 0.11% | -6.0% |
| Q2 2016 | $283,000 | +40.8% | 8,733 | +37.7% | 0.12% | +27.2% |
| Q4 2014 | $201,000 | – | 6,340 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |